Barclays lowered the firm’s price target on Carlyle to $47 from $56 and keeps an Overweight rating on the shares post the Q1 report. Fundraising and management fees missed expectations, and while management reaffirmed fiscal year fundraising and earnings targets, the tone felt more cautious on the near-term outlook for realizations, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- CG Earnings this Week: How Will it Perform?
- Carlyle-backed Crescent Midstream weighs potential sale, Bloomberg reports
- Carlyle price target raised to $60 from $58 at JMP Securities
- Carlyle price target raised to $56 from $55 at Barclays
- Carlyle weighing strategic options for StandardAero, Reuters reports